Income Statement GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:07 2024-09-13 EDT			5-day change	1st Jan Change
1,633.50 ^GBX	-0.31%		-1.09%	+12.64%

09-13	Moderna's Faces 'Material Headwinds' on RSV, COVID, RBC Says	MT
09-13	GSK Bets on Blood-Cancer Drug Comeback Amid Oncology Push	DJ

8a1d8ff36c8ca83.bhUBwORg7HbkM50xg8MFLZqmPJGMFYR8lwJIAXnh2IA.XX9PgrMD3zO0YMlm3LJGXOjODPbBUdM57VsQS0_RsdFdQ2X33VitO65k9g

Published financial data: GSK PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	33.75B	34.1B	34.11B	29.32B	30.33B
Total Revenues	33.75B	34.1B	34.11B	29.32B	30.33B
Cost of Goods Sold, Total	10.79B	10.89B	11.45B	9.41B	8.39B
Gross Profit	22.96B	23.21B	22.66B	19.92B	21.94B
Selling General & Admin Expenses, Total	10.6B	10.5B	10.19B	8.18B	9.16B
R&D Expenses	4.4B	4.68B	4.88B	5.15B	5.82B
Other Operating Expenses	-606M	-455M	-373M	-737M	-1.44B
Other Operating Expenses, Total	14.4B	14.73B	14.69B	12.6B	13.54B
Operating Income	8.56B	8.48B	7.97B	7.32B	8.4B
Interest Expense, Total	-877M	-860M	-775M	-819M	-710M
Interest And Investment Income	79M	39M	26M	62M	108M
Net Interest Expenses	-798M	-821M	-749M	-757M	-602M
Income (Loss) On Equity Invest.	74M	33M	33M	-2M	-5M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-12M	-21M	-4M	-46M	-75M
EBT, Excl. Unusual Items	7.83B	7.67B	7.25B	6.52B	7.72B
Restructuring Charges	-1.11B	-1.53B	-628M	-321M	-382M
Gain (Loss) On Sale Of Investments	129M	-242M	1M	256M	-121M
Gain (Loss) On Sale Of Assets	399M	3.01B	591M	215M	61M
Asset Writedown	-83M	-263M	-322M	-296M	-398M
Legal Settlements	-363M	-231M	-52M	922M	-
Other Unusual Items	-579M	-1.45B	-1.39B	-1.66B	-817M
EBT, Incl. Unusual Items	6.22B	6.97B	5.44B	5.63B	6.06B
Income Tax Expense	953M	580M	346M	707M	756M
Earnings From Continuing Operations	5.27B	6.39B	5.1B	4.92B	5.31B
Earnings Of Discontinued Operations	-	-	-	10.5B	-
Net Income to Company	5.27B	6.39B	5.1B	15.42B	5.31B
Minority Interest	-623M	-639M	-711M	-460M	-380M
Net Income - (IS)	4.64B	5.75B	4.38B	14.96B	4.93B
Net Income to Common Incl Extra Items	4.64B	5.75B	4.38B	14.96B	4.93B
Net Income to Common Excl. Extra Items	4.64B	5.75B	4.38B	4.46B	4.93B
Per Share Items
Net EPS - Basic	1.17	1.44	1.1	3.71	1.22
Basic EPS - Continuing Operations	1.17	1.44	1.1	1.11	1.22
Basic Weighted Average Shares Outstanding	3.96B	3.98B	4B	4.03B	4.05B
Net EPS - Diluted	1.16	1.43	1.08	3.66	1.2
Diluted EPS - Continuing Operations	1.16	1.43	1.08	1.09	1.2
Diluted Weighted Average Shares Outstanding	4.01B	4.03B	4.05B	4.08B	4.11B
Normalized Basic EPS	1.08	1.04	0.95	0.9	1.1
Normalized Diluted EPS	1.06	1.03	0.94	0.88	1.08
Dividend Per Share	1	1	1	0.61	0.58
Payout Ratio	85.1	69.18	91.2	23.18	45.6
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	10.45B	10.37B	9.9B	9.47B	10.3B
EBITA	9.43B	9.38B	8.92B	8.41B	9.41B
EBIT	8.56B	8.48B	7.97B	7.32B	8.4B
EBITDAR	10.48B	10.4B	9.92B	9.49B	10.33B
Effective Tax Rate - (Ratio)	15.32	8.32	6.36	12.56	12.47
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	1.14B	1.27B	1.35B	1.49B	1.62B
Total Deferred Taxes	-183M	-693M	-1B	-784M	-865M
Normalized Net Income	4.27B	4.16B	3.82B	3.61B	4.45B
Interest Capitalized	-	15M	16M	21M	36M
Interest on Long-Term Debt	65M	55M	47M	51M	74M
Non-Cash Pension Expense	75M	82M	50M	37M	73M
Supplemental Operating Expense Items
Advertising Expense	1.57B	1.78B	1.81B	735M	835M
Selling and Marketing Expenses	1.57B	1.78B	-	-	-
Research And Development Expense From Footnotes	4.57B	5.1B	5.28B	5.49B	6.22B
Net Rental Expense, Total	29M	27M	20M	17M	27M
Imputed Operating Lease Interest Expense	7.19M	6.56M	4.93M	5.06M	8.26M
Imputed Operating Lease Depreciation	21.81M	20.44M	15.07M	11.94M	18.74M
Stock-Based Comp., Other (Total)	432M	393M	404M	346M	307M
Total Stock-Based Compensation	432M	393M	404M	346M	307M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	4.71B	6.29B	4.27B	3.72B	2.94B
Short Term Investments	786M	480M	614M	750M	450M
Trading Asset Securities, Total	353M	63M	77M	4.25B	2.3B
Total Cash And Short Term Investments	5.85B	6.84B	4.96B	8.72B	5.69B
Accounts Receivable, Total	5.49B	5.55B	6.25B	5.45B	5.9B
Other Receivables	941M	1.3B	1.21B	969M	1.08B
Notes Receivable	13M	11M	18M	11M	9M
Total Receivables	6.44B	6.86B	7.48B	6.43B	7B
Inventory	5.95B	6B	5.78B	5.15B	5.5B
Prepaid Expenses	316M	359M	315M	343M	355M
Other Current Assets, Total	941M	195M	133M	123M	108M
Total Current Assets	19.49B	20.25B	18.67B	20.77B	18.64B
Gross Property Plant And Equipment	21.72B	21.46B	20.7B	19.36B	19.59B
Accumulated Depreciation	-10.41B	-10.45B	-10.02B	-9.74B	-9.63B
Net Property Plant And Equipment	11.31B	11.01B	10.67B	9.62B	9.96B
Long-term Investments	2.16B	3.5B	2.28B	1.58B	1.22B
Goodwill	10.56B	10.6B	10.55B	7.05B	6.81B
Other Intangibles, Total	30.96B	29.82B	30.08B	14.32B	14.77B
Deferred Tax Assets Long-Term	4.1B	4.29B	5.22B	5.66B	6.05B
Other Long-Term Assets, Total	1.12B	974M	1.63B	1.16B	1.56B
Total Assets	79.69B	80.43B	79.1B	60.15B	59B
Liabilities
Accounts Payable, Total	4.14B	4.36B	4.54B	3.87B	3.72B
Accrued Expenses, Total	8.34B	8.73B	9.97B	4.04B	4.08B
Short-term Borrowings	4.97B	1.05B	707M	1.49B	893M
Current Portion of Long-Term Debt	1.71B	2.45B	2.69B	2.3B	1.76B
Current Portion of Leases	240M	230M	203M	167M	156M
Current Income Taxes Payable	629M	545M	489M	471M	500M
Unearned Revenue Current, Total	158M	361M	307M	299M	222M
Other Current Liabilities	3.86B	4.43B	4.76B	10.19B	9.73B
Total Current Liabilities	24.05B	22.15B	23.67B	22.81B	21.07B
Long-Term Debt	22.58B	22.54B	19.76B	16.19B	14.15B
Long-Term Leases	1.01B	887M	812M	841M	1.05B
Unearned Revenue Non Current	24M	21M	85M	83M	254M
Pension & Other Post Retirement Benefits	3.46B	3.65B	3.11B	2.58B	2.34B
Deferred Tax Liability Non Current	3.81B	3.6B	3.56B	289M	311M
Other Non Current Liabilities	6.4B	6.78B	6.76B	7.25B	7.03B
Total Liabilities	61.34B	59.62B	57.76B	50.05B	46.21B
Common Stock, Total	1.35B	1.35B	1.35B	1.35B	1.35B
Additional Paid In Capital	3.17B	3.28B	3.3B	3.44B	3.45B
Retained Earnings	5.05B	7.29B	8.75B	4.79B	7.74B
Comprehensive Income and Other	1.83B	2.67B	1.66B	1.02B	805M
Total Common Equity	11.4B	14.59B	15.06B	10.6B	13.35B
Minority Interest	6.95B	6.22B	6.29B	-502M	-552M
Total Equity	18.36B	20.81B	21.34B	10.1B	12.8B
Total Liabilities And Equity	79.69B	80.43B	79.1B	60.15B	59B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.96B	3.98B	4.01B	4.03B	4.06B
ECS Total Common Shares Outstanding	3.96B	3.98B	4.01B	4.03B	4.06B
Book Value / Share	2.88	3.66	3.76	2.63	3.29
Tangible Book Value	-30.11B	-25.83B	-25.58B	-10.77B	-8.23B
Tangible Book Value Per Share	-7.6	-6.48	-6.38	-2.67	-2.03
Total Debt	30.51B	27.15B	24.17B	20.99B	18.02B
Net Debt	24.66B	20.32B	19.21B	12.26B	12.33B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.92B	2.1B	1.13B	1.36B	763M
Debt Equivalent Oper. Leases	232M	216M	160M	136M	216M
Minority Interest, Total (Incl. Fin. Div)	6.95B	6.22B	6.29B	-502M	-552M
Equity Method Investments, Total	314M	364M	88M	74M	55M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.2B	1.17B	1.77B	1.58B	1.59B
Inventories - Work In Process, Total	2.5B	2.4B	1.89B	2.29B	2.45B
Inventories - Finished Goods, Total	2.25B	2.43B	2.12B	1.28B	1.46B
Land - (BS)	7.25B	7.21B	6.95B	6.39B	6.22B
Machinery, Total	11.62B	11.55B	11.3B	10.48B	10.34B
Full Time Employees	99.44K	94.07K	90.1K	69.4K	70.21K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	130M	151M	150M	91M	85M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	4.64B	5.75B	4.38B	14.96B	4.93B
Depreciation & Amortization - CF	1.23B	1.21B	1.2B	1.06B	1.08B
Amortization of Goodwill and Intangible Assets - (CF)	870M	896M	957M	1.09B	1.01B
Depreciation & Amortization, Total	2.1B	2.11B	2.15B	2.15B	2.09B
Amortization of Deferred Charges, Total - (CF)	233M	241M	225M	-	203M
(Gain) Loss From Sale Of Asset	-543M	-3.26B	-606M	-221M	-12M
(Gain) Loss on Sale of Investments - (CF)	-2M	-69M	28M	-1M	-1M
Asset Writedown & Restructuring Costs	825M	781M	523M	198M	360M
(Income) Loss On Equity Investments - (CF)	-74M	-33M	-33M	2M	5M
Stock-Based Compensation (CF)	365M	381M	367M	346M	307M
Net Cash From Discontinued Operations	-	-	-	769M	-
Other Operating Activities, Total	99M	2.58B	714M	-9.44B	-257M
Change In Accounts Receivable	-32M	-224M	-782M	-158M	-794M
Change In Inventories	300M	119M	25M	-269M	-424M
Change In Accounts Payable	263M	225M	284M	494M	-15M
Change in Other Net Operating Assets	-160M	-159M	670M	-1.42B	377M
Cash from Operations	8.02B	8.44B	7.95B	7.4B	6.77B
Capital Expenditure	-1.26B	-1.23B	-1.17B	-1.14B	-1.31B
Sale of Property, Plant, and Equipment	95M	68M	143M	146M	28M
Cash Acquisitions	-3.68B	-105M	-114M	-3.19B	-1.47B
Divestitures	104M	259M	-17M	-43M	49M
Sale (Purchase) of Intangible assets	-494M	242M	-987M	-919M	-1.02B
Investment in Marketable and Equity Securities, Total	-199M	2.85B	334M	95M	1.78B
Other Investing Activities, Total	89M	70M	36M	-3.72B	346M
Cash from Investing	-5.35B	2.16B	-1.78B	-8.77B	-1.6B
Short Term Debt Issued, Total	3.1B	-	318M	1.02B	-
Long-Term Debt Issued, Total	4.79B	3.3B	-	1.02B	223M
Total Debt Issued	7.89B	3.3B	318M	2.05B	223M
Short Term Debt Repaid, Total	-4.16B	-7.3B	-2.31B	-5.07B	-2.45B
Long-Term Debt Repaid, Total	-214M	-227M	-215M	-1.8B	-341M
Total Debt Repaid	-4.37B	-7.53B	-2.53B	-6.87B	-2.79B
Issuance of Common Stock	51M	29M	21M	25M	10M
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-3.95B	-3.98B	-4B	-3.47B	-2.25B
Common & Preferred Stock Dividends Paid	-3.95B	-3.98B	-4B	-3.47B	-2.25B
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-1.45B	-1.95B	-1.4B	9.09B	-837M
Cash from Financing	-1.84B	-10.13B	-7.59B	823M	-5.64B
Foreign Exchange Rate Adjustments	-82M	-39M	-29M	152M	-99M
Net Change in Cash	744M	431M	-1.44B	-394M	-567M
Supplemental Items
Cash Interest Paid	895M	864M	786M	848M	766M
Cash Income Tax Paid (Refund)	1.51B	1.66B	1.29B	1.31B	1.33B
Levered Free Cash Flow	5.01B	8.05B	6.47B	4.95B	3.56B
Unlevered Free Cash Flow	5.56B	8.59B	6.95B	5.46B	4.01B
Change In Net Working Capital	801M	-1.52B	-1.35B	-454M	1.52B
Net Debt Issued / Repaid	3.52B	-4.23B	-2.21B	-4.82B	-2.57B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	7.77	6.62	6.24	6.57	8.82
Return on Total Capital	13.62	10.95	10.65	11.95	16.97
Return On Equity %	47.83	32.62	24.18	31.31	46.38
Return on Common Equity	61.17	44.24	29.59	34.78	41.16
Margin Analysis
Gross Profit Margin %